AIRJ AirJoule Technologies | $1.75 -0.3% | 11/17/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of AirJoule Technologies (NASDAQ:AIRJ) on 11/17/2026 |
QTI QT Imaging | $1.64 -3.0% | 10/23/2026 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for D. Boral Capital rating of QT Imaging (NASDAQ:QTI) on 10/23/2026 |
AIRJ AirJoule Technologies | $1.75 -0.3% | 10/2/2026 | | Initiated Coverage | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of AirJoule Technologies (NASDAQ:AIRJ) on 10/2/2026 |
TRT Trio-Tech International | $4.68 -1.1% | 9/28/2026 | | Initiated Coverage | $17.00 | Buy | 00.00% | View details for D. Boral Capital rating of Trio-Tech International (NYSE:TRT) on 9/28/2026 |
EVEX EVE | $1.47 -4.2% | 8/21/2026 | | Initiated Coverage | $6.00 | Buy | 00.00% | View details for D. Boral Capital rating of EVE (NYSE:EVEX) on 8/21/2026 |
HITI High Tide | $2.38 +0.6% | 7/22/2026 | | Initiated Coverage | $4.00 | Buy | 00.00% | View details for D. Boral Capital rating of High Tide (NASDAQ:HITI) on 7/22/2026 |
ANIX Anixa Biosciences | $2.75 +3.0% | 6/30/2026 | | Initiated Coverage | $10.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 6/30/2026 |
WWR Westwater Resources | $0.37 -1.2% | 6/11/2026 | | Initiated Coverage | $3.00 | Buy | 00.00% | View details for D. Boral Capital rating of Westwater Resources (NASDAQ:WWR) on 6/11/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 5/5/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 5/5/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 5/5/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 5/5/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
CLNN Clene | $3.38 +5.0% | 5/4/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 5/4/2026 |
LCTX Lineage Cell Therapeutics | $0.85 +4.2% | 5/4/2026 | | Reiterated Rating | $3.00 | Buy | 00.00% | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 5/4/2026 |
MNOV MediciNova | $1.38 +2.6% | 5/4/2026 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for D. Boral Capital rating of MediciNova (NASDAQ:MNOV) on 5/4/2026 |
PRLD Prelude Therapeutics | $3.34 +0.6% | 5/4/2026 | | Initiated Coverage | $9.00 | Buy | 00.00% | View details for D. Boral Capital rating of Prelude Therapeutics (NASDAQ:PRLD) on 5/4/2026 |
FATN Fatpipe Inc/UT | $4.15 -0.8% | 5/1/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of Fatpipe Inc/UT (NASDAQ:FATN) on 5/1/2026 |
LUNG Pulmonx | $2.70 -1.1% | 4/30/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 4/30/2026 |
OSTX OS Therapies | $0.86 +15.6% | 4/30/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for D. Boral Capital rating of OS Therapies (NYSEAMERICAN:OSTX) on 4/30/2026 |
BMEA Biomea Fusion | $0.48 -2.7% | 4/28/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 4/28/2026 |
HUMA Humacyte | $0.50 -1.0% | 4/28/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 4/28/2026 |
CMPX Compass Therapeutics | $0.61 -0.3% | 4/27/2026 | | Reiterated Rating | $30.00 | Buy | 00.00% | View details for D. Boral Capital rating of Compass Therapeutics (NASDAQ:CMPX) on 4/27/2026 |
CRMD CorMedix | $4.55 -2.7% | 4/27/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 4/27/2026 |
CRVO CervoMed | $1.49 -1.0% | 4/22/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 4/22/2026 |
HUMA Humacyte | $0.50 -1.0% | 4/21/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 4/21/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 4/21/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/21/2026 |
OMER Omeros | $14.28 +2.6% | 4/21/2026 | | Reiterated Rating | $36.00 | Buy | 00.00% | View details for D. Boral Capital rating of Omeros (NASDAQ:OMER) on 4/21/2026 |
BEAT HeartBeam | $0.34 +2.8% | 4/20/2026 | | Downgrade | | Buy ➝ Hold | 00.00% | View details for D. Boral Capital rating of HeartBeam (NASDAQ:BEAT) on 4/20/2026 |
NNOX Nano-X Imaging | $0.28 -3.7% | 4/20/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 4/20/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 4/20/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 4/20/2026 |
TRVI Trevi Therapeutics | $13.78 +2.0% | 4/17/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 4/17/2026 |
EVTL Vertical Aerospace | $0.30 +4.7% | 4/16/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 4/16/2026 |
IMUX Immunic | $7.51 +2.4% | 4/15/2026 | | Downgrade | | Buy ➝ Hold | 00.00% | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 4/15/2026 |
VERI Veritone | $0.35 -2.5% | 4/15/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 4/15/2026 |
HOVR New Horizon Aircraft | $1.18 +0.8% | 4/14/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 4/14/2026 |
NNOX Nano-X Imaging | $0.28 -3.7% | 4/13/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 4/13/2026 |
ADUR Aduro Clean Technologies | $8.80 -4.0% | 4/10/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 4/10/2026 |
COYA Coya Therapeutics | $3.06 +1.4% | 4/10/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 4/10/2026 |
ANIX Anixa Biosciences | $2.75 +3.0% | 4/8/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 4/8/2026 |
BMEA Biomea Fusion | $0.48 -2.7% | 4/8/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 4/8/2026 |
CRVO CervoMed | $1.49 -1.0% | 4/8/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 4/8/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 4/8/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 4/8/2026 |
Under 3 cents a night (Ad) Bill Poulos's Black Friday deal: a full year of the Instant Scanner for $7, one payment. The regular price is $247, about a dollar a night.
With roughly 250 trading nights a year, that's 2.8 cents a night to have nearly a thousand of America's biggest stocks checked, with exact buy prices on whatever qualifies.
No re-bills and nothing to install. At $7, the only question is whether you get around to it. Get a full year of the Instant Scanner for just $7. |
OSTX OS Therapies | $0.86 +15.6% | 4/8/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for D. Boral Capital rating of OS Therapies (NYSEAMERICAN:OSTX) on 4/8/2026 |
RCEL Avita Medical | $17.56 +11.4% | 4/8/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 4/8/2026 |
ANIX Anixa Biosciences | $2.75 +3.0% | 3/31/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anixa Biosciences (NASDAQ:ANIX) on 3/31/2026 |
AVXL Anavex Life Sciences | $0.73 -1.2% | 3/31/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 3/31/2026 |
EVTL Vertical Aerospace | $0.30 +4.7% | 3/31/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/31/2026 |
URGN Urogen Pharma | $28.56 -4.4% | 3/31/2026 | | Reiterated Rating | $33.00 | Buy | 00.00% | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 3/31/2026 |
BEAT HeartBeam | $0.34 +2.8% | 3/27/2026 | | Initiated Coverage | $5.00 | Buy | 00.00% | View details for D. Boral Capital rating of HeartBeam (NASDAQ:BEAT) on 3/27/2026 |
HUMA Humacyte | $0.50 -1.0% | 3/27/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/27/2026 |
OSTX OS Therapies | $0.86 +15.6% | 3/27/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for D. Boral Capital rating of OS Therapies (NYSEAMERICAN:OSTX) on 3/27/2026 |
VERI Veritone | $0.35 -2.5% | 3/27/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/27/2026 |
CTSO Cytosorbents | $4.64 +2.5% | 3/26/2026 | | Reiterated Rating | $200.00 | Buy | 00.00% | View details for D. Boral Capital rating of Cytosorbents (NASDAQ:CTSO) on 3/26/2026 |
BMEA Biomea Fusion | $0.48 -2.7% | 3/25/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Biomea Fusion (NASDAQ:BMEA) on 3/25/2026 |
CNTX Context Therapeutics | $0.16 -5.8% | 3/24/2026 | | Reiterated Rating | $9.00 | Buy | 00.00% | View details for D. Boral Capital rating of Context Therapeutics (NASDAQ:CNTX) on 3/24/2026 |
EVTL Vertical Aerospace | $0.30 +4.7% | 3/24/2026 | | Reiterated Rating | $12.00 | Buy | 00.00% | View details for D. Boral Capital rating of Vertical Aerospace (NYSE:EVTL) on 3/24/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 3/24/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/24/2026 |
TTRX Turn Therapeutics | $9.26 +8.3% | 3/24/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of Turn Therapeutics (NASDAQ:TTRX) on 3/24/2026 |
AVXL Anavex Life Sciences | $0.73 -1.2% | 3/23/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 3/23/2026 |
FATN Fatpipe Inc/UT | $4.15 -0.8% | 3/23/2026 | | Initiated Coverage | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of Fatpipe Inc/UT (NASDAQ:FATN) on 3/23/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 3/23/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/23/2026 |
TRVI Trevi Therapeutics | $13.78 +2.0% | 3/18/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/18/2026 |
HUMA Humacyte | $0.50 -1.0% | 3/17/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 3/17/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 3/17/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/17/2026 |
VERI Veritone | $0.35 -2.5% | 3/17/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/17/2026 |
COYA Coya Therapeutics | $3.06 +1.4% | 3/16/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 3/16/2026 |
CRVO CervoMed | $1.49 -1.0% | 3/16/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/16/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 3/16/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/16/2026 |
CLNN Clene | $3.38 +5.0% | 3/12/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of Clene (NASDAQ:CLNN) on 3/12/2026 |
CTXR Citius Pharmaceuticals | $0.51 -1.3% | 3/11/2026 | | Reiterated Rating | $6.00 | Buy | 00.00% | View details for D. Boral Capital rating of Citius Pharmaceuticals (NASDAQ:CTXR) on 3/11/2026 |
BSIN Big Sky Industrial Inc. Common Stock | $1.07 +0.9% | 3/10/2026 | | Reiterated Rating | $3.50 | Buy | 00.00% | View details for D. Boral Capital rating of Big Sky Industrial Inc. Common Stock (NASDAQ:BSIN) on 3/10/2026 |
ADUR Aduro Clean Technologies | $8.80 -4.0% | 3/9/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 3/9/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 3/9/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 3/9/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 3/9/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 3/9/2026 |
OSTX OS Therapies | $0.86 +15.6% | 3/9/2026 | | Reiterated Rating | $20.00 | Buy | 00.00% | View details for D. Boral Capital rating of OS Therapies (NYSEAMERICAN:OSTX) on 3/9/2026 |
TRVI Trevi Therapeutics | $13.78 +2.0% | 3/9/2026 | | Reiterated Rating | $19.00 | Buy | 00.00% | View details for D. Boral Capital rating of Trevi Therapeutics (NASDAQ:TRVI) on 3/9/2026 |
LCTX Lineage Cell Therapeutics | $0.85 +4.2% | 3/6/2026 | | Boost Price Target | $2.00 ➝ $3.00 | Buy | 00.00% | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 3/6/2026 |
LUNG Pulmonx | $2.70 -1.1% | 3/5/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 3/5/2026 |
MVIS Microvision | $0.91 -5.8% | 3/5/2026 | | Downgrade | | Buy ➝ Hold | 00.00% | View details for D. Boral Capital rating of Microvision (NASDAQ:MVIS) on 3/5/2026 |
CRVO CervoMed | $1.49 -1.0% | 3/4/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 3/4/2026 |
TVGN Tevogen Bio | $5.90 +3.7% | 3/4/2026 | | Downgrade | | Buy ➝ Hold | 00.00% | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/4/2026 |
NNOX Nano-X Imaging | $0.28 -3.7% | 3/3/2026 | | Reiterated Rating | $5.00 | Buy | 00.00% | View details for D. Boral Capital rating of Nano-X Imaging (NASDAQ:NNOX) on 3/3/2026 |
TVGN Tevogen Bio | $5.90 +3.7% | 3/3/2026 | | Lower Price Target | $250.00 ➝ $100.00 | Buy | 00.00% | View details for D. Boral Capital rating of Tevogen Bio (NASDAQ:TVGN) on 3/3/2026 |
VERI Veritone | $0.35 -2.5% | 3/3/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 3/3/2026 |
URGN Urogen Pharma | $28.56 -4.4% | 3/2/2026 | | Reiterated Rating | $33.00 | Buy | 00.00% | View details for D. Boral Capital rating of Urogen Pharma (NASDAQ:URGN) on 3/2/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 2/23/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/23/2026 |
LUNG Pulmonx | $2.70 -1.1% | 2/20/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of Pulmonx (NASDAQ:LUNG) on 2/20/2026 |
HUMA Humacyte | $0.50 -1.0% | 2/19/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/19/2026 |
COYA Coya Therapeutics | $3.06 +1.4% | 2/18/2026 | | Reiterated Rating | $15.00 | Buy | 00.00% | View details for D. Boral Capital rating of Coya Therapeutics (NASDAQ:COYA) on 2/18/2026 |
CRVO CervoMed | $1.49 -1.0% | 2/18/2026 | | Reiterated Rating | $31.00 | Buy | 00.00% | View details for D. Boral Capital rating of CervoMed (NASDAQ:CRVO) on 2/18/2026 |
IBRX ImmunityBio | $6.61 +5.6% | 2/17/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for D. Boral Capital rating of ImmunityBio (NASDAQ:IBRX) on 2/17/2026 |
NRXP NRx Pharmaceuticals | $2.71 +10.4% | 2/17/2026 | | Reiterated Rating | $34.00 | Buy | 00.00% | View details for D. Boral Capital rating of NRx Pharmaceuticals (NASDAQ:NRXP) on 2/17/2026 |
Drop these 5 stocks before the market opens tomorrow! (Ad) The Wall Street Journal called it the "$64 trillion question": is a stock market crash on the way? Weiss Ratings' latest research says 2026 could be very rough for some well-known stocks.
A major shift now taking shape in the market could hit some of America's most-loved names hard. Weiss analysts have pinpointed five stocks they believe investors should steer clear of while it plays out. See the five stocks Weiss Ratings analysts are watching closely now. |
RCEL Avita Medical | $17.56 +11.4% | 2/17/2026 | | Reiterated Rating | $10.00 | Buy | 00.00% | View details for D. Boral Capital rating of Avita Medical (NASDAQ:RCEL) on 2/17/2026 |
IMUX Immunic | $7.51 +2.4% | 2/13/2026 | | Lower Price Target | $80.00 ➝ $40.00 | Buy | 00.00% | View details for D. Boral Capital rating of Immunic (NASDAQ:IMUX) on 2/13/2026 |
ADUR Aduro Clean Technologies | $8.80 -4.0% | 2/11/2026 | | Reiterated Rating | $46.00 | Buy | 00.00% | View details for D. Boral Capital rating of Aduro Clean Technologies (NASDAQ:ADUR) on 2/11/2026 |
CRMD CorMedix | $4.55 -2.7% | 2/11/2026 | | Reiterated Rating | $14.00 | Buy | 00.00% | View details for D. Boral Capital rating of CorMedix (NASDAQ:CRMD) on 2/11/2026 |
HOVR New Horizon Aircraft | $1.18 +0.8% | 2/11/2026 | | Reiterated Rating | $11.00 | Buy | 00.00% | View details for D. Boral Capital rating of New Horizon Aircraft (NASDAQ:HOVR) on 2/11/2026 |
VERI Veritone | $0.35 -2.5% | 2/11/2026 | | Reiterated Rating | $23.00 | Buy | 00.00% | View details for D. Boral Capital rating of Veritone (NASDAQ:VERI) on 2/11/2026 |
AVXL Anavex Life Sciences | $0.73 -1.2% | 2/9/2026 | | Reiterated Rating | $24.00 | Buy | 00.00% | View details for D. Boral Capital rating of Anavex Life Sciences (NASDAQ:AVXL) on 2/9/2026 |
ESLA Estrella Immunopharma | $0.36 +8.0% | 2/9/2026 | | Reiterated Rating | $8.00 | Buy | 00.00% | View details for D. Boral Capital rating of Estrella Immunopharma (NASDAQ:ESLA) on 2/9/2026 |
HUMA Humacyte | $0.50 -1.0% | 2/9/2026 | | Reiterated Rating | $25.00 | Buy | 00.00% | View details for D. Boral Capital rating of Humacyte (NASDAQ:HUMA) on 2/9/2026 |
LCTX Lineage Cell Therapeutics | $0.85 +4.2% | 2/9/2026 | | Reiterated Rating | $2.00 | Buy | 00.00% | View details for D. Boral Capital rating of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) on 2/9/2026 |